Pharmacopoeia to be online soon

| | New Delhi
  • 0

Pharmacopoeia to be online soon

Monday, 10 December 2018 | PNS | New Delhi

Soon, pharmacopoeia standards for drugs/formulations used under Ayurveda, Siddha, Unani (ASU) and Homoeopathic systems of medicine will be available at a click of mouse. The move, a first-of-its kind is in keeping with the Government’s vision ‘Digital India’ as well as to reach out to local manufacturers to help them produce quality and safe alternate drugs whose demand is on increase in domestic and global market.

To begin with, the website of Ayurveda Pharmacopoeia  giving scientific details of over 700 ayurveda drugs will be launched by Union Ayush Minister Shripad Naik on December 13 at a symposium to be organised by the Pharmacopoeia Commission for Indian Medicine and Homeopathy (PCIM&H). It is an autonomous body under the Ministry with a primary mandate to develop pharmacopoeial standards for drugs/formulations used under ASU and Homoeopathic systems of medicine.

“The Pharmacopoeias are official documents and are widely used all over the India. These are the compendia of quality standards to ensure the identity, purity and strength of the drug imported, manufactured for sale, stocked or exhibited for sale or distributed in the country.

“With the launch of the website, these documents will be accessible online as well,” said Dr KRC Reddy, Director of the PCIM&H.

He further explained that while demand for the herbal drug is on rise, many manufacturers are still unaware that they have to adhere the standards and quality control parameters as given in the authoritative books, pharmacopoeias and formularies of  these medical system, which are different from that prescribed for allopathic medicines.

The symposium aims to disseminate awareness among them about these standards they have to mandatorily follow,  Dr Reddy said  adding that researchers, academicians, regulators and industry related to ayurveda are expected to participate in the event.

So far pharmacopeia of 400 single molecule drugs under Ayurveda category and 300 drugs of double molecules has been prepared. We are working to add on more drugs in the repository, he added.

Sancht Sharma from AIMIL Pharma, manufacturer of anti-diabetes herbal  drug BGR-34 and Leukoskin to treat white patches (Luckemia) said that these are just some of the measures being taken recently to ensure quality and safety. “These are officially accepted legal documents providing quality parameters for ayurveda drugs. World is looking at ayurveda with great hopes and it becomes important for us to cash in on this demand by maintaining quality.”

The Government has already made it mandatory for the industry to comply with the Pharmacopoeias and Formularies prescribed in the Drugs and Cosmetics Act, 1940 and Rules 1945 in the manufacturing of ASU and homoeopathic drugs, he maintained.

Sunday Edition

CAA PASSPORT TO FREEDOM

24 March 2024 | Kumar Chellappan | Agenda

CHENNAI EXPRESS IN GURUGRAM

24 March 2024 | Pawan Soni | Agenda

The Way of Bengal

24 March 2024 | Shobori Ganguli | Agenda

The Pizza Philosopher

24 March 2024 | Shobori Ganguli | Agenda

Astroturf | Lord Shiva calls for all-inclusiveness

24 March 2024 | Bharat Bhushan Padmadeo | Agenda

Interconnected narrative l Forest conservation l Agriculture l Food security

24 March 2024 | BKP Sinha/ Arvind K jha | Agenda